This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Salud financiera de hoja de balance de Nuvo Pharmaceuticals
Salud financiera controles de criterios 1/6
Información clave
1,149.7%
Ratio deuda-patrimonio
CA$97.55m
Deuda
| Ratio de cobertura de intereses | 1.3x |
| Efectivo | CA$31.26m |
| Patrimonio | CA$8.49m |
| Total pasivo | CA$118.77m |
| Activos totales | CA$127.26m |
Actualizaciones recientes sobre salud financiera
Nuvo Pharmaceuticals (TSE:MRV) Has A Somewhat Strained Balance Sheet
Aug 17
Is Nuvo Pharmaceuticals (TSE:MRV) Using Too Much Debt?
Sep 01These 4 Measures Indicate That Nuvo Pharmaceuticals (TSE:MRV) Is Using Debt Extensively
Feb 22Recent updates
Nuvo Pharmaceuticals (TSE:MRV) Has A Somewhat Strained Balance Sheet
Aug 17Is Nuvo Pharmaceuticals (TSE:MRV) Using Too Much Debt?
Sep 01Nuvo Pharmaceuticals Inc.'s (TSE:MRV) CEO Might Not Expect Shareholders To Be So Generous This Year
May 11These 4 Measures Indicate That Nuvo Pharmaceuticals (TSE:MRV) Is Using Debt Extensively
Feb 22Análisis de la situación financiera
Pasivos a corto plazo: MRV's short term assets (CA$51.8M) exceed its short term liabilities (CA$24.6M).
Pasivo a largo plazo: MRV's short term assets (CA$51.8M) do not cover its long term liabilities (CA$94.2M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: MRV's net debt to equity ratio (781.3%) is considered high.
Reducción de la deuda: MRV's debt to equity ratio has increased from 0% to 1149.7% over the past 5 years.
Cobertura de la deuda: MRV's debt is not well covered by operating cash flow (15.9%).
Cobertura de intereses: MRV's interest payments on its debt are not well covered by EBIT (1.3x coverage).